Ovarian Cancer Industry, May 2015 Market Reports from Top Publishers

You might be interested in: Diagnostics, Oncology, Drug, Biomarker, Cancer Diagnostic, Clinical Trial.


 
1-10 of 26 reports for Ovarian Cancer

Purchase Reports From Reputable Market Research Publishers

 Epithelial Ovarian Cancer-Pipeline Insights, 2015

Epithelial Ovarian Cancer-Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Epithelial Ovarian Cancer- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Epithelial Ovarian Cancer. The main objective of this report ...

 Metastatic Ovarian Cancer-Pipeline Insights, 2015

Metastatic Ovarian Cancer-Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Metastatic Ovarian Cancer- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Metastatic Ovarian Cancer. The main objective of this report ...

Metastatic Ovarian Cancer-API Insights, 2015

Metastatic Ovarian Cancer-API Insights, 2015

  • $ 1 250
  • Industry report
  • April 2015
  • by Delve Insight

Summary DelveInsight’s, Metastatic Ovarian Cancer-API Insights, 2015,report provides Metastatic Ovarian Cancer drugs marketed details and API Manufacturers details across the globe along with the location. ...

Ovarian Cancer-API Insights, 2015

Ovarian Cancer-API Insights, 2015

  • $ 1 250
  • Industry report
  • April 2015
  • by Delve Insight

Summary DelveInsight’s, Ovarian Cancer-API Insights, 2015,report provides Ovarian Cancer drugs marketed details and API Manufacturers details across the globe along with the location. The report gives ...

Metastatic Ovarian Cancer - Pipeline Review, H1 2015

Metastatic Ovarian Cancer - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • March 2015
  • by Global Markets Direct

Metastatic Ovarian Cancer - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Metastatic Ovarian Cancer - Pipeline Review, H1 2015’, provides an overview of the Metastatic Ovarian Cancer’s ...

Ovarian Cancer Partnering 2010-2015

Ovarian Cancer Partnering 2010-2015

  • $ 995
  • Industry report
  • March 2015
  • by Currentpartnering

The Ovarian Cancer Partnering 2010-2015 report provides understanding and access to the ovarian cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in ...

Metastatic Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Metastatic Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight’s, “Metastatic Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed ...

Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight’s, “Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 - Off-patent Chemo-regimens to Retain Dominance Despite New Launches

Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 - Off-patent Chemo-regimens to Retain Dominance Despite New Launches

  • $ 4 995
  • Industry report
  • January 2015
  • by GBI Research

Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 - Off-patent Chemo-regimens to Retain Dominance Despite New Launches Summary GBI Research, a leading business intelligence provider, has released ...

Ovarian Cancer Drug Pathway Analyzer 2015

Ovarian Cancer Drug Pathway Analyzer 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 349 targeted molecular therapies known to affect more than 250 specific intracellular signaling pathways ...

About 2 700 reports for Ovarian Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the UK

  • January 2013
    123 pages
  • Ovarian Cancer  

    Oncology  

    Chemotherapy  

  • United Kingdom  

View report >

Pathology Description

December 2013

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.